ltrasonographic study of the effects of the herbal medicine package on the size of fibroma

Phase 3

Recruiting

• Conditions: terine fibroids.; Maternal care for benign tumor of corpus uteri; O34.1

• Registration Number: IRCT20141209020258N147
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

15 to 49 years
Having a uterine fibroid smaller millimetre
No history of uterine cancer in the individual and first-degree relatives
No pregnancy
No breastfeeding
Lack of uterine bleeding, colitis, hemorrhoids, appendicitis, intestinal obstruction, acute inflammatory bowel diseases such as Crohn's disease, ulcerative colitis, abdominal pain of unknown origin, gastric bleeding and esophageal varices
Absence of underlying disease

Exclusion Criteria

Dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fibroma size. Timepoint: Before and after three months of treatment. Method of measurement: Sonography.